Skip to content

Hexafluronium

MUSCULO-SKELETAL SYSTEM

Also known as: hexafluorenium bromide, hexafluorenium dibromide, hexafluronium bromide

OfmFDA approvedATC M03AC05

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Hexafluronium is an ofm drug catalogued in DrugCentral. DrugCentral lists 3 molecular targets, including BCHE, ache and ACHE.

  • Approval status: ofm.
  • Molecular targets: BCHE, ache and ACHE (3 listed in DrugCentral).
  • ATC code: M03AC05 (Other quaternary ammonium compounds).
  • Molecular formula: C36H42N2; molecular weight 502.75 g/mol.

Mechanism & targets

Molecular targets (3)

TargetGeneActionActivity
ButyrylcholinesteraseBCHEunknownKi 6.47
AcetylcholinesteraseacheunknownKi 5.89
AcetylcholinesteraseACHEinhibitor—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
—FDA—MEDPOINTE PHARM HLC

ATC classification

ATC codeTherapeutic hierarchy
M03AC05MUSCULO-SKELETAL SYSTEM › MUSCLE RELAXANTS › MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS › Other quaternary ammonium compounds

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Hexafluronium is on its molecule page.

Molecular formulaC36H42N2
Molecular weight502.75 g/mol
CAS number317-52-2
InChIKeyHDZAQYPYABGTCL-UHFFFAOYSA-N
PubChem CID3601
C[N+](C)(CCCCCC[N+](C)(C)C1C2=CC=CC=C2C2=C1C=CC=C2)C1C2=CC=CC=C2C2=C1C=CC=C2

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Hexafluronium work?

Its molecular targets in DrugCentral include BCHE, ache and ACHE (inhibitor).

What is the chemical formula of Hexafluronium?

Hexafluronium has the molecular formula C36H42N2 and a molecular weight of 502.75 g/mol.

Browse: all drugs starting with H · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval—
AgencyFDA
Targets3
Indications0
FormulaC36H42N2
DrugCentral ID1365
Interactive profile